Press Releases 

Helomics® Corporation and SpeciCare, Inc. sign Letter of Intent to provide personalized medicine opp

PITTSBURGH– July 9, 2018 - Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions and boutique CRO services for clients in the pharmaceutical, diagnostic, and biotechnology industries, and SpeciCare, Inc., an innovative Georgia based company connecting cancer patients to new treatment options only available through storing the patients live tumor tissue, today announced that they have signed a joint Letter of Intent to provide new opportunities for precision oncology and personalized medicine for cancer patients through their joint business offerings. The two organizations plan to partner on a variety of activities from go-to-market i

Archive
 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon